PKC-beta inhibitor ruboxistaurin influences visual loss in diabetic retinopathy

Publikace na 1. lékařská fakulta |

2006

Protein kinase C-beta inhibition, ruboxistaurin, retinopathy, macular edema, PKC-DRC trial